Combined chemotherapy and radiation improves survival for node-positive endometrial cancer

Gynecologic Oncology

Volumn 127, Issue 1, 2012, Pages 32-37

  Lee, Larissa J ^a   Viswanathan, Akila N ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Endometrioid histology; FIGO IIIC endometrial cancer; Node positive endometrial cancer; Radiation therapy

Indexed keywords

ANASTROZOLE; CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; MEGESTROL ACETATE; PACLITAXEL;

ABDOMINAL HYSTERECTOMY; ADULT; AGED; ARTICLE; BRACHYTHERAPY; CANCER CHEMOTHERAPY; CANCER CONTROL; CANCER PATIENT; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER RELAPSE; CANCER STAGING; CANCER SURVIVAL; DISEASE FREE SURVIVAL; ENDOMETRIUM CANCER; EXTERNAL BEAM RADIOTHERAPY; FEMALE; FOLLOW UP; HUMAN; LYMPH NODE DISSECTION; LYMPH VESSEL METASTASIS; MAJOR CLINICAL STUDY; MULTIMODALITY CANCER THERAPY; MULTIPLE CYCLE TREATMENT; OVERALL SURVIVAL; PARAAORTIC LYMPH NODE; PELVIS LYMPH NODE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK FACTOR; SALPINGOOOPHORECTOMY; SURVIVAL RATE; THORAX RADIOGRAPHY; TREATMENT OUTCOME; TUMOR VOLUME;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, ENDOMETRIOID; CHEMORADIOTHERAPY, ADJUVANT; CHEMOTHERAPY, ADJUVANT; DISEASE-FREE SURVIVAL; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; MIDDLE AGED; RADIOTHERAPY, ADJUVANT; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 84865692661     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2012.06.026     Document Type: Article

References (22)

1. C.P. Morrow, B.N. Bundy, and R.J. Kurman Relationship between surgical-pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium: a Gynecologic Oncology Group study Gynecol Oncol 40 1991 55 65
2. M.S. Piver, S.B. Lele, J.J. Barlow, and L. Blumenson Paraaortic lymph node evaluation in stage I endometrial carcinoma Obstet Gynecol 59 1982 97 100
3. M.L. Hicks, M.S. Piver, and J.L. Puretz Survival in patients with paraaortic lymph node metastases from endometrial adenocarcinoma clinically limited to the uterus Int J Radiat Oncol Biol Phys 26 1993 607 611
4. S. Pecorelli Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium Int J Gynaecol Obstet 105 2009 103 104
5. G. Nelson, M. Randall, G. Sutton, D. Moore, J. Hurteau, and K. Look FIGO stage IIIC endometrial carcinoma with metastases confined to pelvic lymph nodes: analysis of treatment outcomes, prognostic variables, and failure patterns following adjuvant radiation therapy Gynecol Oncol 75 1999 211 214
6. K.M. Greven, W.J. Curran Jr., and R. Whittington Analysis of failure patterns in stage III endometrial carcinoma and therapeutic implications Int J Radiat Oncol Biol Phys 17 1989 35 39
7. A.J. Mundt, K.T. Murphy, J. Rotmensch, S.E. Waggoner, S.D. Yamada, and P.P Connell Surgery and postoperative radiation therapy in FIGO Stage IIIC endometrial carcinoma Int J Radiat Oncol Biol Phys 50 2001 1154 1160
8. J.O. Schorge, K.L. Molpus, A. Goodman, N. Nikrui, and A.F. Fuller Jr. The effect of postsurgical therapy on stage III endometrial carcinoma Gynecol Oncol 63 1996 34 39
9. T. Onda, H. Yoshikawa, and K. Mizutani Treatment of node-positive endometrial cancer with complete node dissection, chemotherapy and radiation therapy Br J Cancer 75 1997 1836 1841
10. A.H. Klopp, A. Jhingran, L. Ramondetta, K. Lu, D.M. Gershenson, and P.J. Eifel Node-positive adenocarcinoma of the endometrium: outcome and patterns of recurrence with and without external beam irradiation Gynecol Oncol 115 2009 6 11
11. B.W. Corn, R.M. Lanciano, and K.M. Greven Endometrial cancer with para-aortic adenopathy: patterns of failure and opportunities for cure Int J Radiat Oncol Biol Phys 24 1992 223 227
12. N. Takeshima, K. Umayahara, K. Fujiwara, Y. Hirai, K. Takizawa, and K. Hasumi Effectiveness of postoperative chemotherapy for para-aortic lymph node metastasis of endometrial cancer Gynecol Oncol 102 2006 214 217
13. H. Watari, Y. Todo, M. Takeda, Y. Ebina, R. Yamamoto, and N. Sakuragi Lymph-vascular space invasion and number of positive para-aortic node groups predict survival in node-positive patients with endometrial cancer Gynecol Oncol 96 2005 651 657
14. M. Hiura, T. Nogawa, T. Matsumoto, T. Yokoyama, Y. Shiroyama, and J. Wroblewski Long-term survival in patients with para-aortic lymph node metastasis with systematic retroperitoneal lymphadenectomy followed by adjuvant chemotherapy in endometrial carcinoma Int J Gynecol Cancer 20 2010 1000 1005
15. M.E. Randall, N.M. Spirtos, and P. Dvoretsky Whole abdominal radiotherapy versus combination chemotherapy with doxorubicin and cisplatin in advanced endometrial carcinoma (phase III): Gynecologic Oncology Group Study No. 122 J Natl Cancer Inst Monogr 1995 13 15
16. R. Maggi, A. Lissoni, and F. Spina Adjuvant chemotherapy vs radiotherapy in high-risk endometrial carcinoma: results of a randomised trial Br J Cancer 95 2006 266 271
17. N. Susumu, S. Sagae, and Y. Udagawa Randomized phase III trial of pelvic radiotherapy versus cisplatin-based combined chemotherapy in patients with intermediate- and high-risk endometrial cancer: a Japanese Gynecologic Oncology Group study Gynecol Oncol 108 2008 226 233
18. K. Greven, K. Winter, K. Underhill, J. Fontenesci, J. Cooper, and T. Burke Final analysis of RTOG 9708: adjuvant postoperative irradiation combined with cisplatin/paclitaxel chemotherapy following surgery for patients with high-risk endometrial cancer Gynecol Oncol 103 2006 155 159
19. T. Hogberg, M. Signorelli, and C.F. de Oliveira Sequential adjuvant chemotherapy and radiotherapy in endometrial cancer - results from two randomised studies Eur J Cancer 46 2010 2422 2431
20. H. Kitchener, A.M. Swart, Q. Qian, C. Amos, and M.K. Parmar Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomised study Lancet 373 2009 125 136
21. P. Benedetti Panici, S. Basile, and F. Maneschi Systematic pelvic lymphadenectomy vs. no lymphadenectomy in early-stage endometrial carcinoma: randomized clinical trial J Natl Cancer Inst 100 2008 1707 1716
22. N.S. Horowitz, F. Dehdashti, and T.J. Herzog Prospective evaluation of FDG-PET for detecting pelvic and para-aortic lymph node metastasis in uterine corpus cancer Gynecol Oncol 95 2004 546 551